Fluoropharma Medical Valuation
| FPMI Stock | USD 0.0001 0.00 0.00% |
Fluoropharma Medical seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Fluoropharma Medical from reviewing the firm fundamentals such as Price To Earning of (0.39) X, shares outstanding of 34.26 M, and Net Income of (2.05 M) as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Fluoropharma Medical's price fluctuation is very steady at this time. Calculation of the real value of Fluoropharma Medical is based on 3 months time horizon. Increasing Fluoropharma Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Fluoropharma Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fluoropharma Pink Sheet. However, Fluoropharma Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Fluoropharma Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Fluoropharma Medical's stock price.
Estimating the potential upside or downside of Fluoropharma Medical helps investors to forecast how Fluoropharma pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fluoropharma Medical more accurately as focusing exclusively on Fluoropharma Medical's fundamentals will not take into account other important factors: Fluoropharma Medical Total Value Analysis
Fluoropharma Medical is currently expected to have valuation of 9.23 M with market capitalization of 3.43 M, debt of 5.82 M, and cash on hands of 24.72 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Fluoropharma Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.23 M | 3.43 M | 5.82 M | 24.72 K |
Fluoropharma Medical Asset Utilization
One of the ways to look at asset utilization of Fluoropharma is to check how much profit was generated for every dollar of assets it reports. Fluoropharma Medical shows a negative utilization of assets of -2.35 percent, losing $0.0235 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Fluoropharma Medical shows how discouraging it operates for each dollar spent on its assets.Fluoropharma Medical Ownership Allocation
Fluoropharma Medical holds a total of 34.26 Million outstanding shares. Roughly 99.66 percent of Fluoropharma Medical outstanding shares are held by general public with 0.34 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Fluoropharma Medical Profitability Analysis
Net Loss for the year was (2.05 M) with profit before overhead, payroll, taxes, and interest of 0.About Fluoropharma Medical Valuation
An absolute valuation paradigm, as applied to Fluoropharma Pink Sheet, attempts to find the value of Fluoropharma Medical based on its fundamental and basic technical indicators. By analyzing Fluoropharma Medical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Fluoropharma Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fluoropharma Medical. We calculate exposure to Fluoropharma Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fluoropharma Medical's related companies.FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. Fluoropharma Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
8 Steps to conduct Fluoropharma Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Fluoropharma Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Fluoropharma Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Fluoropharma Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Fluoropharma Medical's revenue streams: Identify Fluoropharma Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Fluoropharma Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Fluoropharma Medical's growth potential: Evaluate Fluoropharma Medical's management, business model, and growth potential.
- Determine Fluoropharma Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Fluoropharma Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Fluoropharma Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -35.2 M |
Complementary Tools for Fluoropharma Pink Sheet analysis
When running Fluoropharma Medical's price analysis, check to measure Fluoropharma Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluoropharma Medical is operating at the current time. Most of Fluoropharma Medical's value examination focuses on studying past and present price action to predict the probability of Fluoropharma Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluoropharma Medical's price. Additionally, you may evaluate how the addition of Fluoropharma Medical to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |